Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

The discovery in the early 1990s that administration in mice of plasmid DNA encoding both viral and nonviral antigens induced antibody responses held out the prospect of achieving broad immunogenicity ...

Plasmid DNA (pDNA) is an essential component of molecular biotechnology applications, such as protein expression and gene therapy. Large scale plasmid purification (maxi-prep) is labor-intensive, time ...

Plasmid DNA can be used across an extensive range of applications. Therefore, ensuring the supply is purified in the right way is crucial for every given situation. Analytik Jena‘s CyBio FeliX Liquid ...

Antibody production can slow research to a crawl. As senior vice president of Biointron, Lei Shi works with scientists around the globe to optimize and expedite their antibody projects, from start to ...

Adeno-associated viruses (AAV) have emerged as pivotal delivery vehicles for gene therapy due to their overall safety (less immunogenic), efficiency (broad tropism), and long-term gene expression.

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

Transfection alters the genetic makeup of eukaryotic cells by introducing foreign nucleic acids, including DNA, RNA, and small noncoding RNAs such as siRNA, shRNA, and miRNA. Scientists use ...

Adenoviral vectors will transduce a wide range of target cells resulting in high-level gene expression. They are non-integrating vectors so expression in dividing cells is progressively lost. First ...